Posttransplant lymphoproliferative disorder after liver transplantation in miniature swine

被引:9
作者
Talpe, S
Oike, F
Dehoux, JP
Sempoux, C
Rahier, J
Otte, JB
Gianello, P
机构
[1] Catholic Univ Louvain, Sch Med, Expt Surg Lab, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium
[3] Clin Univ St Luc, Dept Pediat Surg, B-1200 Brussels, Belgium
关键词
D O I
10.1097/00007890-200106150-00032
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Posttransplant lymphoproliferative disorder (PTLD) is a well-known, life-threatening complication of immunosuppressive therapy, occurring in both adult and pediatric transplant recipients. Methods. To study the effect of major histocompatibility complex on tolerance induction to primarily vascularized liver allograft, a semi-identical miniature swine model was developed to mimic the clinical situation of parent-into-infant liver transplantation, Long-term acceptance of semi-identical liver allograft was obtained by a transient course of FK506, In a subgroup of six animals, three developed a lethal PTLD, These animals were studied by histology and immunohistochemistry and the anti-donor cellular immune response was assessed, In addition, the possible viral origin of the proliferative process was evoked. Results, Histology and immunohistochemistry revealed an abnormal B-cell proliferation in many organs of swine suffering from PTLD, Evidence of human Epstein-Barr virus, cytomegalovirus, and adenovirus was not evidenced, but a porcine virus responsible for a respiratory and reproductive syndrome (PRRS) was identified in the lymphoid tissue of these animals. In mixed lymphocyte reaction, a significant antiself immune response confirmed an infection by a virus. Conclusions, This is the first report suggesting that PEES virus might provoke PTLD in immunosuppressed miniature swine after orthotopic liver transplantation. Whether PTLD could be induced by injection of the PRRS virus in immunosuppressed animals, a pig model of PTLD might be developed and would represent an interesting preclinical model for testing anti-PTLD therapies.
引用
收藏
页码:1684 / 1688
页数:5
相关论文
共 50 条
[31]   Plasmacytic Posttransplant Lymphoproliferative Disorder With Hyperviscosity Syndrome in a Child After Liver Transplant [J].
Yang, Christine H. ;
Gombar, Saurabh ;
Twist, Clare J. ;
Gratzinger, Dita ;
Esquivel, Carlos O. ;
Lau, Audrey H. .
HEPATOLOGY, 2016, 64 (06) :2250-2252
[32]   Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review [J].
Sprangers, Ben ;
Riella, Leonardo, V ;
Dierickx, Daan .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (02) :272-281
[33]   Prevalence of monoclonal immunoglobulins after liver transplantation - Relationship with posttransplant lymphoproliferative disorders [J].
Pageaux, GP ;
Bonnardet, A ;
Picot, MC ;
Perrigault, PF ;
Coste, V ;
Navarro, F ;
Fabre, JM ;
Domergue, J ;
Descomps, B ;
Blanc, P ;
Michel, H ;
Larrey, D .
TRANSPLANTATION, 1998, 65 (03) :397-400
[34]   Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation [J].
Smets, F ;
Vajro, P ;
Cornu, G ;
Reding, R ;
Otte, JB ;
Sokal, E .
TRANSPLANTATION, 2000, 69 (05) :982-984
[35]   Posttransplant Lymphoproliferative Disease after Lung Transplantation [J].
Neuringer, Isabel P. .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
[36]   HCV infection and posttransplant lymphoproliferative disorders (PTLD) after liver transplantation (LT). [J].
Hézode, C ;
Duvoux, C ;
Germanidis, G ;
Roudot-Thoraval, F ;
Cherqui, D ;
Pawlotsky, JM ;
Dhumeaux, D .
HEPATOLOGY, 1998, 28 (04) :260A-260A
[37]   Posttransplant Lymphoproliferative Disorder [J].
Ahn, B. ;
Paspulati, R. ;
Coffey, M. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05)
[38]   Posttransplant lymphoproliferative disorder [J].
Everly, Matthew J. ;
Bloom, Roy D. ;
Tsai, Donald E. ;
Trofe, Jennifer .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) :1850-1858
[39]   POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER [J].
BASGOZ, N ;
PREIKSAITIS, JK .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1995, 9 (04) :901-&
[40]   First Experience With Brentuximab Vedotin in Posttransplant Lymphoproliferative Disorder After Liver Transplantation: Complete Remission Followed by Lethal Sepsis [J].
Schaefer, Benedikt ;
Steurer, Michael ;
Glodny, Bernhard ;
Neureiter, Daniel ;
Moser, Patrizia ;
Dorn, Livia ;
Vogel, Wolfgang ;
Zoller, Heinz .
LIVER TRANSPLANTATION, 2014, 20 (09) :1145-1148